Considerable evidence has been presented to link growth and maturation of granulocytic leukocytes with cellular nucleic acid metabolism. The mechanisms of this relationship, however, remain unclear. Thus, Thorell (1), by microspectrophotometric techniques, has correlated the concentration of ribonucleic acid (RNA) present in the cytoplasm and nucleolus with growth potentialities of the blood cell. He showed that during maturation, cellular RNA concentration decreased progressively, paralleling the declining growth activity of the cell. Furthermore, he demonstrated the failure of rapidly proliferating cells in acute leukemia to show the rapid decline in RNA metabolism which is seen in normally proliferating cells following their active growth phase.
Considerable evidence has been presented to link growth and maturation of granulocytic leukocytes with cellular nucleic acid metabolism. The mechanisms of this relationship, however, remain unclear. Thus, Thorell (1) , by microspectrophotometric techniques, has correlated the concentration of ribonucleic acid (RNA) present in the cytoplasm and nucleolus with growth potentialities of the blood cell. He showed that during maturation, cellular RNA concentration decreased progressively, paralleling the declining growth activity of the cell. Furthermore, he demonstrated the failure of rapidly proliferating cells in acute leukemia to show the rapid decline in RNA metabolism which is seen in normally proliferating cells following their active growth phase.
These differences in RNA content between immature and mature blood cells have been confirmed by Davidson, Leslie, and White (2) . In this study, peripheral blood cells showed a significantly lower content of RNA phosphorus than bone marrow cells both in normal and in leukemic persons. However, decrease in the content of desoxyribonucleic (DNA) phosphorus in peripheral blood cells as compared with marrow cells was of borderline significance.
Further evidence relating cell growth with nucleic acid metabolism is found in the clinical response of some of the leukemias to substances, including folic acid antagonists, nitrogen mustards, urethane, cortisone and arsenic, which have been shown to inhibit biological synthesis of nucleic acid (3, 4) . Furthermore, clinical observations by Vilter and his associates (5) relate the aberrant erythropoiesis in megaloblastic anemias with abnormal nucleic acid metabolism conditioned by deficiences of Vitamin B19 and folic acid.
Abnormalities in nucleic acid metabolism associated with aberrant cell growth in the leukemic organism might be reflected in the urinary excretion of intermediary products derived from these metabolic processes. In the present study, chromatographic and ultraviolet spectroscopic techniques have led to the identification of ultraviolet absorbing substances in the urine of persons with myeloid leukemia which are not present in the urine of non-leukemic subjects. One of these substances has been identified as uracil, a pyrimidine component of RNA.
MATERIAL AND METHODS
Five consecutive adult patients with myeloid leukemia admitted to the medical service of the University Hospitals of Cleveland served as subjects in this study. The peripheral blood hemograms of these patients at the time of this study are shown in Table I . Four of these (J. S., B. W., E. W., and J. McK.) presented a clinical diagnosis of chronic myeloid leukemia with peripheral leukocytosis, splenomegaly, anemia, and granulocytic hyperplasia in the bone marrow. The fifth patient (R. N.) was diagnosed as having leukemia of a myelomonocytic type. Although the peripheral leukocyte count of this patient was not greatly increased, abnormally young forms were noted in stained blood films; and the bone marrow showed marked leukocytic hyperplasia with 53 per cent blast forms.
Three patients (J. McK., E. W., and R. N.) had received no previous therapy. Patient J. S., had received two courses of splenic irradiation 16 and 10 months prior to this study. Patient B. W., had undergone a splenectomy elsewhere six years previous to this study. She had received radioactive phosphorus one year previously when a diagnosis of chronic myeloid leukemia was established. At the time of this study, hepatomegaly and adenopathy were marked and bone marrow biopsy revealed moderate myelofibrosis.
In addition, four non-leukemic patients on the medical wards of the hospital were studied as controls.
In order to minimize the urinary excretion of substances with ultraviolet absorption at wave lengths characteristic of nucleic acid derivatives (260-290 millimicrons), all subjects in the study were placed on an animal-protein-free diet with restriction of coffee, tea, and 901 
RESULTS
Representative diagrams of ultraviolet absorbing components in normal and leukemic urine eluted from the anion exchange column are seen in Figures la and lb, respectively. Comparison of these two elution graphs shows in each instance the presence of two absorbing peaks, both of which are greater in the leukemic than in non-leukemic urine. The increased absorption of the first peak was seen in all five of the leukemic specimens examined (Table II) , ranging in the leukemic urine from 5900 to 11,260 and in the normals fr,om 3700 to 5480 260 mpu absorption units 2 per 24 hours. Paper chromatography of this fraction in normal urines showed the development of one ultraviolet absorbing component with an Rf value of 0.78 (Figure 2 ). This component was also present in leukemic urines and gave a positive quali- 2 The number of absorption units was obtained by multiplying the volume of the effluent fraction by its optical density at the wave length specified. This value was then multiplied by 100 for the total 24 hour quantitation. tative test for phenols (8) . Four ultraviolet fluorescent spots were also developed; these did not show significant absorption, however.
In paper chromatograms of this fraction from three of the leukemic urines examined ( Figure  2A ), an ultraviolet absorbing substance with an Rf value of 0.7 was seen; this compound was not present in normal urine. In all three instances, the ultraviolet spectrum of this component was the same (Figure 3a) and was similar to that of uracil (Figure 3b) . Also, this compound was similar to uracil in its paper (Figure 2, Ur) not present in normal urine. The ultraviolet absorption spectrum of this component was the same in both specimens and is recorded in Figure 4 .
Further, characterization of this component has not been accomplished. Nothing in the clinical evaluation of these patients was apparent to explain the presence of this different component in the urine of these two patients.
The second ultraviolet absorbing fraction of the elution diagrams (Peak II, Figure la and to demonstrate a proportional rise in uric acid excretion which would reflect increased breakdown of purine moieties of ntucleic acid. Speculatively, the latter miiechanism might imply some abnormality in the intermediary metabolism of pyrimidines. Further study is needed, however, for clarification of this as a possible metabolic aberration in these patients. Increase(I endogenous uracil might also result from a deficiency in enzyme systems concerned in the catabolism of the pyrimidine ring to urea and oxalic acid. U'racil tolerance studies in normiial and in leukemic persons now in progress in this laboratory may provide information concerning this as a possible mechanism.
The significance of the abnormal ultraviolet absorbing component recovered in patients J. McK. and E. W. awaits further characterization of this substance. However, its presence in two leukemic patients and its absence in normiials suggests some relationship to the leukemic process in these individuals.
SUM MARY 1. Abnormiial ultraviolet absorbing substances have been identified in the uirine of fivre l)atients with myeloid leukemiiia.
2. In three of these patients, the pyriniidine uracil has been identified spectroscopically, chromatographically, and mlicrobiologically.
3. In the other two patients, another substance, identified chromatographicallv and spectroscopically, was excreted; this suibstance has not been further characterized.
